AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $89.63M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| TOT | Update - Dividend/Distribution - TOT | 24/04/18 | ||
| TOT | Change in substantial holding | 03/04/18 | ||
| TOT | Dividend/Distribution - TOT | PRICE SENSITIVE | 22/03/18 | |
| TOT | Investment Update | PRICE SENSITIVE | 08/03/18 | |
| TOT | 1H18 Interim Report 360 Capital Total Return Active Fund | 28/02/18 | ||
| TOT | 1H18 Results Presentation | 28/02/18 | ||
| TOT | 1H18 Results Announcement | PRICE SENSITIVE | 28/02/18 | |
| TOT | Appendix 4D and 1H18 Interim Report | PRICE SENSITIVE | 28/02/18 | |
| TOT Update - Dividend/Distribution - TOT | |||
| 24/04/18 | |||
| TOT Change in substantial holding | |||
| 03/04/18 | |||
| TOT Dividend/Distribution - TOT | |||
| 22/03/18 | PRICE SENSITIVE | ||
| TOT Investment Update | |||
| 08/03/18 | PRICE SENSITIVE | ||
| TOT 1H18 Interim Report 360 Capital Total Return Active Fund | |||
| 28/02/18 | |||
| TOT 1H18 Results Presentation | |||
| 28/02/18 | |||
| TOT 1H18 Results Announcement | |||
| 28/02/18 | PRICE SENSITIVE | ||
| TOT Appendix 4D and 1H18 Interim Report | |||
| 28/02/18 | PRICE SENSITIVE | ||
